Nephron Pharmaceuticals Corporation, a South Carolina-based company that develops and produces safe, affordable generic inhalation solutions and suspension products, announced on Thursday that it has named Julie Rameas as its new chief procurement officer.
In the new role, Rameas will manage all strategic sourcing and procurement activities.
Rameas has experience in pharmaceutical, medical device, metal, electronic, aerospace, automotive, and textile manufacturing industries. She has held the position of senior director of Global Strategic Procurement at Thermo Fisher Scientific and served in global director roles at Lear Corporation. She has also worked at BioMerieux, where she led spending on all chemicals, biologics and controlled substances.
Mikart adds Fette double-sided tablet presses
Biocon Biologics enters five-year partnership with Sandoz Australia
Mallinckrodt names new directors
Rottendorf Pharma enhances operations with Rockwell Automation's FactoryTalk PharmaSuite MES
Teva Pharmaceuticals secures FDA approval for generic Forteo (teriparatide injection)
Upsher-Smith Laboratories introduces Pitavastatin Tablets
Par Pharmaceutical starts shipping colchicine 0.6mg capsules
Padagis launces Brinzolamide Ophthalmic Suspension with CGT exclusivity
Novartis completes Sandoz spin-off, focusing on innovative medicines
Sanofi and Teva collaborate on innovative IBD treatment
Hikma marks KLOXXADO two-year anniversary by surpassing 375,000 doses donated in the US
STADA seeks full approval for Kinpeygo in IgA nephropathy from UK MHRA
Azurity Pharmaceuticals completes Slayback Pharma acquisition